Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arbutus Biopharma Corp ABUS

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is leveraging its virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can potentially be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV) infection. Its HBV product pipeline includes Imdusiran and AB-101. Imdusiran is its proprietary, conjugated GalNAc, subcutaneously delivered RNAi therapeutic product candidate. AB-101 is an oral PD-L1 inhibitor that has the potential to reawaken patients’ HBV-specific immune response by inhibiting PD-L1. Its pipeline includes two product candidates that target various steps in the HBV viral lifecycle and consists of various programs: RNAi therapeutic (imdusiran, AB-729) and Oral PD-L1 Inhibitor (AB-101). RNAi therapeutics utilize a natural pathway within cells to silence genes by eliminating the disease-causing proteins that they code for.


NDAQ:ABUS - Post by User

Bullboard Posts
Post by j_harbaughon Dec 31, 2014 1:25pm
196 Views
Post# 23276133

Thin L2, low P/E, insider buying and stock buyback

Thin L2, low P/E, insider buying and stock buybackIf you want to invest in a stock with a lot of catalysts to cause a price spike, check out GPW. It has:

1. A very thin L2 on the ask.
2. Low P/E
3. Insider buying
4. A stock buyback was announced.

GPW has nearly doubled in price this week on almost 1M volume. Part of the volume has been insider buying, where 130K shares were purchased at 4 cents on Dec 29 and 200K shares were purchased by another insider at 6.5 cents earlier in the year. Reference:


https://canadianinsider.com/node/7?menu_tickersearch=gpw

The EPS is 2 cents on a 6 cent stock for a P/E of only 3. Reference:

https://web.tmxmoney.com/quote.php?qm_symbol=GPW

The company is repurchasing 3.77M shares this year, per the news release posted below. This bodes well for current investors since only 260K shares sit on the ask to 18 cents. It's possible that the 792K bids that have appeared at 3 to 5 cents are more insider buy orders or the company trying to repurchase more shares. This offers tremendous downside protection for investors which is important given the performance of other TSXV stocks. A buy of GPW now should be an easy double thanks to the insider buying, low P/E, share repurchase plan and not a lot of shares being up for sale.


https://web.tmxmoney.com/article.php?newsid=72126721&qm_symbol=GPW

https://www.tmxmoney.com/TMX/HttpController?GetPage=DelayedMarketByPrice&SelectedSymbol=GPW&Market=V&Language=en


Delayed Market Depth By Price Summary

Last Market by Price Update: 31 Dec 2014 10:41 ET

Instrument Name: Grand Power Logistics Group Inc. Symbol: GPW

The market data displayed is provided on a 15-minute delayed basis and we do not guarantee its accuracy or completeness. Please refer to the date/time stamp above to obtain the age of the data in this table.

Orders Volume Price Range
24 792,000 0.03000-0.05000
Price Range Volume Orders
0.06000-0.18000 260,000 10
As of 11:59pm ET December 30th, 2014
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Dec 30/14 Dec 29/14 Chan, Alan Pui Fai Direct Ownership Common Shares 10 - Acquisition in the public market 130,000 $0.040
Jul 28/14 Jul 25/14 Tse, Decky Chi Kwan Direct Ownership Common Shares 10 - Acquisition in the public market 100,000 $0.065
Jul 28/14 Jul 24/14 Tse, Decky Chi Kwan Direct Ownership Common Shares 10 - Acquisition in the public market 100,000 $0.065
Sign up for an account or login above to see all SEDI filings within the past 6 months.

Grand Power Logistics Group Inc. Announces Plans to Repurchase Common Shares

CALGARY, ALBERTA--(Marketwired - Dec. 8, 2014) - Grand Power Logistics Group Inc. (the "Corporation" or "Grand Power") (TSX VENTURE:GPW) announces that it has filed with the TSX Venture Exchange a Notice of Intention to Make a Normal Course Issuer Bid which shall commence on December 8, 2014 and terminate on December 7, 2015 or the earlier of the date that all shares which are subject to the Normal Course Issuer Bid are purchased.

In the opinion of the Board of Directors of Grand Power, the market price of the Common Shares of Grand Power does not accurately reflect the value of those shares. As a result, the Corporation intends to repurchase Grand Power's Common Shares that may become available at purchase prices which make the purchases an appropriate use of the funds of the Corporation.

Grand Power intends to attempt to acquire up to an aggregate of 3,773,000 of its Common Shares over the next 12-month period, representing approximately 5% of the issued and outstanding Common Shares of Grand Power.

Purchases subject to the Normal Course Issuer Bid will be carried out pursuant to open market transactions through the facilities of the TSX Venture Exchange. The Member through which the Normal Course Issuer Bid will be conducted is Wolverton Securities, Calgary, Alberta. All Common Shares purchased by Grand Power under the Normal Course Issuer Bid will be cancelled.


Bullboard Posts